Scientists Develop 12-Hour Method to Predict Diabetes Onset in Patients Using Artificial Intelligence
Retrieved on:
Friday, December 2, 2022
Technology, Biotechnology, Diabetes, Health, Artificial Intelligence, Other Science, Other Technology, Research, Software, Hardware, Science, Data Management, Clinical Trials, Consumer Electronics, Consensus, 100 Best Workplaces in Europe, Diabetes, Amanda Ferguson, Type 2, COVID-19, Artificial intelligence, Conference on Neural Information Processing Systems, Inclusion, Type 2 diabetes, Research, Conference, CGM, Sensei, Risk, CGMS-A, Therapy, Human, Severe acute respiratory syndrome coronavirus 2, Glucose, Intelligence, Patient, Ecosystem, Social media, CDC, International Joint Conference on Artificial Intelligence, Prediabetes, Millennials, Biomarker, Physician, Jeon, Science, Blood, Type, IJCAI, Machine learning, Medical device, Pharmaceutical industry, Woman, Paulo, Click, Nature, Health
Scientists at Klick Applied Sciences have discovered a way to transform a continuous glucose monitor (CGM) into a powerful diabetes screening and prevention tool using artificial intelligence.
Key Points:
- Scientists at Klick Applied Sciences have discovered a way to transform a continuous glucose monitor (CGM) into a powerful diabetes screening and prevention tool using artificial intelligence.
- We think CGMs could be used to not just monitor diabetesbut to prevent it altogether.
- For the study, about 600 patients who identified as healthy, prediabetic, or living with Type 2 diabetes wore a CGM device for an average of 12 days.
- They also presented earlier findings at the 2018 International Joint Conference on Artificial Intelligence (IJCAI) in Stockholm, Sweden.